Thomas P. Mechtler

Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria

Thomas P. Mechtler, Thomas Metz, Víctor R. De Jesús et al. · The Lancet · 2012 · 297 citations

Early Diagnosis, Neonatal Screening, Newborn Screening +13

Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes

Albina Nowak, Thomas P. Mechtler, Robert J. Desnick et al. · Molecular Genetics and Metabolism · 2016 · 124 citations · Full text

Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease

Albina Nowak, Thomas P. Mechtler, Thorsten Hornemann et al. · Molecular Genetics and Metabolism · 2017 · 101 citations · Full text

Fabry Disease, Mendelian Disorder, Autoimmune Disease +11

The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response

David C. Kasper, Thomas P. Mechtler, Georg H. Reischer et al. · Diagnostic Microbiology and Infectious Disease · 2010 · 96 citations

Urology, Intrauterine Inflammatory Response, Amniotic Fluid +6

In utero exposure to Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants

David C. Kasper, Thomas P. Mechtler, Judith Rittenschober-Böhm et al. · Journal of Perinatal Medicine · 2011 · 78 citations